The Australian Government is supporting world-leading research into the latest COVID-19 treatments through a dedicated round of the Medical Research Future Fund’s Biomedical Translation Bridge.
The Government, in partnership with the not-for-profit organisation MTPConnect, has announced a new round of its $22.3 million Biomedical Translation Bridge (BTB) Program to support COVID-19 related research projects.
The BTB Program, now launching its third round, is a four-year Australian Government initiative to help researchers transform their ideas into new treatments to help tomorrow’s patients.
This latest round will match funding of up to $1 million per project to help find new COVID-19-related medical devices, diagnostics, vaccines or therapeutic approaches.
The projects must make an impact within 12 months to ensure research can be quickly translated into products and treatment options.
It is hoped the research will help improve the health of Australians and people around the world suffering from COVID-19, as well as create new research jobs.
The Australian Government is proud to provide unprecedented backing for our best and brightest researchers, as Australia and the rest of the world work to limit the spread of COVID-19.
Expressions of interest open on Monday 18 May 2020 and close on Monday 1 June 2020.
Details can be found at the BTB page on MTPConnect’s website.
